echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Wuke University scientific research results: for the "tumor killer" installation of intelligent navigation

    Wuke University scientific research results: for the "tumor killer" installation of intelligent navigation

    • Last Update: 2020-12-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Xin's Network Wuhan, November 9 (Yang Fresh) put the "tumor killer" lysovirus into CAR-T cells, as if for the "killer" installed intelligent navigation, not only to make it accurately find solid tumors, but also remote control to eliminate tumors.
    According to Wuhan University of Science and Technology 9 news, the university's Zhang Tongsheng professor team "CAR-T cell load lysoma virus treatment solid tumor project", recently won the 2020 "Genesis Technology" subversive innovation list.
    CAR-T cell therapy is currently the most cutting-edge cancer treatment in the world, that is, the extraction of T cells from human blood, the use of genetic engineering technology to transform it into car-T cells that can identify and eliminate tumors, and then input them into the patient's body.
    , known in the industry as "the father of CAR-T promotion", and his team found in their research that CAR-T cells and lysomavirus have their own strengths in treating solid tumors. The lysovirus penetrates the tough shell of a solid tumor, and CAR-T cells can accurately locate a solid tumor.
    can you combine the two? After more than two years of hard work, Professor Zhang Tongsun team overcome a number of technical difficulties, creatively put the lysovirus into CAR-T cells, equivalent to the lysovirus installed intelligent navigation, so that it can accurately find solid tumors, and dissolve the solid tumor hard shell, thus opening the door for CAR-T cells "attack", to enter the solid tumor, together to eliminate tumors. Animal trials have shown that the two are "strong combinations" that increase the efficacy of CAR-T therapy by more than 10 times.
    , the technology has entered the clinical trial stage at Concord Hospital Oncology Center of China Central University of Science and Technology.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.